Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment. As with its ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an ...

which has produced “promising” evidence in the clinic through a compassionate use programme suggesting that this class of drugs may relieve injury to the lungs caused by the coronavirus.

Gilead has outlined its plans to develop and ramp up production of its remdesivir COVID-19 drug, with CEO Daniel O’Day pledging to ensure it is affordable after phase 3 results showed it ...

Researchers have shown a new drug compound can prevent long COVID symptoms in mice – a landmark finding that could lead to a future treatment for the debilitating condition.

A new study has found that most COVID-19 treatments approved in the United States are safe and not linked to serious side ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

The compounds identified by Frantz have chemical properties similar to hydroxychloroquine and chloroquine, two immunosuppressive drugs that were previously used to treat and prevent malaria, that have ...

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the ...